Jens J Billgren

age ~42

from Seattle, WA

Also known as:
  • Jens Billgren

Jens Billgren Phones & Addresses

  • Seattle, WA
  • Duvall, WA
  • Bothell, WA

Us Patents

  • Anti-Cgrp Compositions And Use Thereof

    view source
  • US Patent:
    20120294797, Nov 22, 2012
  • Filed:
    May 21, 2012
  • Appl. No.:
    13/476465
  • Inventors:
    Brian Robert Kovacevich - Snohomish WA,
    Leon F. Garcia-Martinez - Woodinville WA,
    Katie Olson - Kenmore WA,
    Benjamin H. Dutzar - Seattle WA,
    Jens J. Billgren - Seattle WA,
    John A. Latham - Seattle WA,
    Danielle M. Mitchell - Seattle WA,
    Patricia Dianne Mcneill - Federal Way WA,
    Nicole M. Janson - Edmonds WA,
    Maria-Cristina Loomis - Bothell WA,
  • International Classification:
    C07K 16/18
    C12N 15/63
    C12N 1/19
    A61K 39/395
    A61K 49/00
    A61K 51/00
    C12Q 1/68
    C12N 5/10
    C12N 1/15
    C12N 1/21
    A61P 25/06
    A61P 3/00
    A61P 35/00
    A61P 25/00
    A61P 29/00
    A61P 19/08
    A61P 1/16
    A61P 13/12
    A61P 13/00
    A61P 3/10
    A61P 37/00
    A61P 9/00
    A61P 19/02
    A61P 11/00
    A61P 11/06
    A61P 25/36
    A61P 15/00
    A61P 17/00
    A61P 17/06
    A61P 25/08
    A61P 25/28
    A61P 17/04
    A61P 1/00
    A61P 37/08
    A61P 31/00
    C12N 15/13
  • US Classification:
    424 111, 5303891, 5303873, 5303913, 5303917, 536 2353, 4353201, 43525423, 4241721, 424 91, 424 96, 5303911, 4241331, 435 61, 435332, 43525411, 43525233, 4241581
  • Abstract:
    The present invention is directed to antibodies and fragments thereof having binding specificity for CGRP. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-CGRP antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-CGRP antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-CGRP antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with CGRP.
  • Anti-Pcsk9 Antibodies And Use Thereof

    view source
  • US Patent:
    20130302399, Nov 14, 2013
  • Filed:
    Mar 12, 2013
  • Appl. No.:
    13/795674
  • Inventors:
    Andrew Lawrence Feldhaus - Lynnwood WA,
    Leon F. Garcia-Martinez - Woodinville WA,
    Benjamin H. Dutzar - Seattle WA,
    Ethan Wayne Ojala - Snohomish WA,
    Brian Robert Kovacevich - Snohomish WA,
    Katie Olson - Kenmore WA,
    Pei Fan - Bothell WA,
    Jens Billgren - Seattle WA,
    Erica Ann Stewart - Shoreline WA,
    Corinne C. Akatsuka - Hilo HI,
    Patricia Dianne McNeill - Federal Way WA,
    Danielle Marie Mitchell - Seattle WA,
    Dan Scott Allison - Lake Forrest Park WA,
    John A. Latham - Seattle WA,
  • International Classification:
    C07K 16/40
    A61K 45/06
    A61K 39/395
  • US Classification:
    424450, 5303898, 5303917, 435188, 5303872, 4241581, 536 2353, 4353201, 435338, 4352523, 43525411, 4352542, 43525423, 43525422, 43525421, 4352543, 4352547, 4352546, 4352544, 435 696, 435 74, 5303913
  • Abstract:
    The present invention is directed to antibodies and fragments thereof having binding specificity for PCSK9. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-PCSK9 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-PCSK9 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-PCSK9 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with PCSK9.
  • Anti-Ngf Compositions And Use Thereof

    view source
  • US Patent:
    20130336975, Dec 19, 2013
  • Filed:
    Mar 15, 2013
  • Appl. No.:
    13/833338
  • Inventors:
    Benjamin H. Dutzar - Seattle WA,
    Brian R. Kovacevich - Snohomish WA,
    Patricia Dianne McNeill - Federal Way WA,
    Danielle M. Mitchell - Seattle WA,
    Ethan W. Ojala - Snohomish WA,
    Pei Fan - Bothell WA,
    Jens Billgren - Seattle WA,
    Erica A. Stewart - Shoreline WA,
    Corinne C. Akatsuka - Hilo HI,
    Betty Yu-Ching Chang - Cupertino CA,
    John A. Latham - Seattle WA,
    Leon F. Garcia-Martinez - Woodinville WA,
  • International Classification:
    C07K 16/22
  • US Classification:
    4241351, 5303892, 5303873, 5303913, 5303917, 536 2353, 4353201, 435335, 4352542, 4352523, 43525411, 435419, 4241581, 435 71, 435328
  • Abstract:
    The present invention is directed to antibodies and fragments thereof having binding specificity for NGF. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.
  • Anti-Ngf Compositions And Use Thereof

    view source
  • US Patent:
    20120148490, Jun 14, 2012
  • Filed:
    Dec 1, 2011
  • Appl. No.:
    13/309295
  • Inventors:
    Benjamin H. Dutzar - Seattle WA,
    Brian R. Kovacevich - Snohomish WA,
    Patricia Dianne NcNeill - Federal Way WA,
    Danielle M. Mitchell - Seattle WA,
    Ethan W. Ojala - Snohomish WA,
    Pei Fan - Bothell WA,
    Jens Billgren - Seattle WA,
    Erica A. Stewart - Shoreline WA,
    Corinne C. Akatsuka - Hilo HI,
    Betty Yu-Ching Chang - Cupertino CA,
    John A. Latham - Seattle WA,
    Leon F. Garcia-Martinez - Woodinville WA,
  • International Classification:
    A61K 39/395
    C12N 15/13
    A61K 49/00
    A61K 51/10
    A61P 29/00
    A61P 25/00
    A61P 19/10
    A61P 35/00
    A61P 1/16
    A61P 25/06
    A61P 31/04
    A61P 21/00
    C12N 15/63
    C12N 5/10
    C12N 1/21
    C12N 1/15
    C12N 1/19
    C12N 9/96
    C12P 21/02
    A61P 37/08
    C07K 16/22
  • US Classification:
    424 149, 5303892, 5303873, 5303913, 536 2353, 4241581, 424 91, 5303917, 5303911, 4353201, 435335, 4352523, 435419, 43525411, 4352542, 43525423, 424 96, 435188, 530367, 435 696, 800 6
  • Abstract:
    The present invention is directed to antibodies and fragments thereof having binding specificity for NGF. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V, Vand CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-NGF antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-NGF antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-NGF antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with NGF.

Get Report for Jens J Billgren from Seattle, WA, age ~42
Control profile